Ivermectin: Evaluation of Efficacy and Safety in COVID-19
The search for an effective and safe COVID-19 therapy involves, among other things, assessment of efficacy of medicines already used for the treatment of other diseases, and having potential antiviral activity against SARS-CoV-2. The relevance of the presented study stems from ambiguous data on the...
Main Authors: | E. V. Shubnikova, N. A. Susekova, T. M. Bukatina, M. S. Galenko, A. A. Druzhinina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2022-04-01
|
Series: | Безопасность и риск фармакотерапии |
Subjects: | |
Online Access: | https://www.risksafety.ru/jour/article/view/277 |
Similar Items
-
COVID-19: Ivermectin; Molecular Mechanisms, Limitations, Suggestions
by: Mustafa KESMEN, et al.
Published: (2020-12-01) -
Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19
by: Hoda Awad, et al.
Published: (2022-08-01) -
Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial
by: Anan Manomaipiboon, et al.
Published: (2022-08-01) -
The use of Ivermectin for the treatment of COVID-19: Panacea or enigma?
by: Helen Onyeaka, et al.
Published: (2022-07-01) -
Ivermectin as a possible treatment for COVID-19: a review of the 2022 protocols
by: L. L. M. Marques, et al.
Published: (2022-05-01)